.ANALYSIS EMPHASIZE.06 August 2024.
A huge randomized measured test with cisgender females highlights the obstacles of adherence to a regular oral preexposure prevention regiment and displays that twice-yearly injection of lenacapavir can easily sustain helpful HIV deterrence levels over 6 months.